166 related articles for article (PubMed ID: 29511623)
1. A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type II.
Shao L; Cui L; Lu J; Lang Y; Bottillo I; Zhao X
FEBS Open Bio; 2018 Mar; 8(3):461-469. PubMed ID: 29511623
[TBL] [Abstract][Full Text] [Related]
2. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.
Yoshida S; Araki Y; Mori T; Sasaki E; Kasagi Y; Isobe K; Susa K; Inoue Y; Bomont P; Okado T; Rai T; Uchida S; Sohara E
Clin Exp Nephrol; 2018 Dec; 22(6):1251-1257. PubMed ID: 29869755
[TBL] [Abstract][Full Text] [Related]
3. Generation and analysis of knock-in mice carrying pseudohypoaldosteronism type II-causing mutations in the cullin 3 gene.
Araki Y; Rai T; Sohara E; Mori T; Inoue Y; Isobe K; Kikuchi E; Ohta A; Sasaki S; Uchida S
Biol Open; 2015 Oct; 4(11):1509-17. PubMed ID: 26490675
[TBL] [Abstract][Full Text] [Related]
4. Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanisms.
Mori Y; Wakabayashi M; Mori T; Araki Y; Sohara E; Rai T; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2013 Sep; 439(1):30-4. PubMed ID: 23962426
[TBL] [Abstract][Full Text] [Related]
5. Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene.
Nakano K; Kubota Y; Mori T; Chiga M; Mori T; Sonoda S; Ueda D; Asakura I; Ikegaya T; Kagawa J; Uchida S; Kubota A
Nephrology (Carlton); 2020 Nov; 25(11):818-821. PubMed ID: 32619053
[TBL] [Abstract][Full Text] [Related]
6. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
[TBL] [Abstract][Full Text] [Related]
7. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.
Lin CM; Cheng CJ; Yang SS; Tseng MH; Yen MT; Sung CC; Lin SH
FASEB J; 2019 Jan; 33(1):1051-1061. PubMed ID: 30148674
[TBL] [Abstract][Full Text] [Related]
8. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
Sohara E; Uchida S
Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
[TBL] [Abstract][Full Text] [Related]
9. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
Boyden LM; Choi M; Choate KA; Nelson-Williams CJ; Farhi A; Toka HR; Tikhonova IR; Bjornson R; Mane SM; Colussi G; Lebel M; Gordon RD; Semmekrot BA; Poujol A; Välimäki MJ; De Ferrari ME; Sanjad SA; Gutkin M; Karet FE; Tucci JR; Stockigt JR; Keppler-Noreuil KM; Porter CC; Anand SK; Whiteford ML; Davis ID; Dewar SB; Bettinelli A; Fadrowski JJ; Belsha CW; Hunley TE; Nelson RD; Trachtman H; Cole TR; Pinsk M; Bockenhauer D; Shenoy M; Vaidyanathan P; Foreman JW; Rasoulpour M; Thameem F; Al-Shahrouri HZ; Radhakrishnan J; Gharavi AG; Goilav B; Lifton RP
Nature; 2012 Jan; 482(7383):98-102. PubMed ID: 22266938
[TBL] [Abstract][Full Text] [Related]
10. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
11.
Sasaki E; Susa K; Mori T; Isobe K; Araki Y; Inoue Y; Yoshizaki Y; Ando F; Mori Y; Mandai S; Zeniya M; Takahashi D; Nomura N; Rai T; Uchida S; Sohara E
Mol Cell Biol; 2017 Apr; 37(7):. PubMed ID: 28052936
[TBL] [Abstract][Full Text] [Related]
12. A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3.
Tsuji S; Yamashita M; Unishi G; Takewa R; Kimata T; Isobe K; Chiga M; Uchida S; Kaneko K
BMC Nephrol; 2013 Jul; 14():166. PubMed ID: 23902721
[TBL] [Abstract][Full Text] [Related]
13. Double synonymous mutations in exon 9 of the Cullin3 gene restore exon inclusion by abolishing hnRNPs inhibition.
Liu Z; Sui A; Wang S; Cui L; Xin Q; Zhang R; Han Y; Shao L; Zhao X
Hum Mol Genet; 2022 Nov; 31(23):4006-4018. PubMed ID: 35796549
[TBL] [Abstract][Full Text] [Related]
14. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
[TBL] [Abstract][Full Text] [Related]
15. Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases.
Uchida S
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):487-93. PubMed ID: 24992566
[TBL] [Abstract][Full Text] [Related]
16. Novel
Chatrathi HE; Collins JC; Wolfe LA; Markello TC; Adams DR; Gahl WA; Werner A; Sharma P
Hypertension; 2022 Jan; 79(1):60-75. PubMed ID: 34878901
[TBL] [Abstract][Full Text] [Related]
17. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).
Glover M; Ware JS; Henry A; Wolley M; Walsh R; Wain LV; Xu S; Van't Hoff WG; Tobin MD; Hall IP; Cook S; Gordon RD; Stowasser M; O'Shaughnessy KM
Clin Sci (Lond); 2014 May; 126(10):721-6. PubMed ID: 24266877
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
Schumacher FR; Siew K; Zhang J; Johnson C; Wood N; Cleary SE; Al Maskari RS; Ferryman JT; Hardege I; Yasmin ; Figg NL; Enchev R; Knebel A; O'Shaughnessy KM; Kurz T
EMBO Mol Med; 2015 Oct; 7(10):1285-306. PubMed ID: 26286618
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel KLHL3-interacting motif in the C-terminal region of WNK4.
Wang L; Wu G; Peng JB
Biochem Biophys Res Commun; 2023 Aug; 670():87-93. PubMed ID: 37285722
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
